(Q40684825)

22 September 2017

Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis (English)

1 reference

22 September 2017

Sakata Y

1

1 reference

22 September 2017

Aoki N

series ordinal

2

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 March 1982

1 reference

Journal of Clinical Investigation

22 September 2017

1 reference

22 September 2017

69

1 reference

22 September 2017

3

1 reference

22 September 2017

536-542

1 reference

Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=371009

The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=371009

Cross-linking of cold-insoluble globulin by fibrin-stabilizing factor

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=371009

Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=371009

Inhibitory spectrum of alpha 2-plasmin inhibitor

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=371009

Congenital Deficiency of α2-Plasmin Inhibitor Associated with Severe Hemorrhagic Tendency *

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=371009

Natural inhibitors of fibrinolysis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=371009

Assay of α2-plasmin inhibitor activity by means of a plasmin specific tripeptide substrate

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=371009

Fast-acting plasmin inhibitor in human plasma

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=371009

Inhibition of Proteases in Coagulation, Kinin-Forming and Complement Systems by α2-Plasmin Inhibitor

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=371009

The primary inhibitor of plasmin in human plasma

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=371009

Identification and Some Properties of a New Fast-Reacting Plasmin Inhibitor in Human Plasma

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=371009

Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=371009

The alpha2-plasmin inhibitor levels in liver diseases

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=371009

The behavior of alpha2-plasmin inhibitor in fibrinolytic states

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=371009

[A quantitative determination of factor 13 with anti-factor 13 serum]

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=371009

Kinetic studies with transglutaminases. The human blood enzymes (activated coagulation factor 13 and the guinea pig hair follicle enzyme

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=371009

Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=371009

Rapid method for the purification of bovine thrombin and the inhibition of the purified enzyme with phenylmethylsulfonyl fluoride

17 June 2018

1 reference

12 December 2020

Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen

1 reference

12 December 2020

Solid state lactoperoxidase: A highly stable enzyme for simple, gentle iodination of proteins

1 reference

12 December 2020

Fibrin-stabilizing factor (factor XIII)

1 reference

12 December 2020

Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin

1 reference

12 December 2020

Fibrinolytic states in a patient with congenital deficiency of alpha 2-plasmin inhibitor

1 reference

12 December 2020

Influence of alpha 2-plasmin inhibitor on adsorption of plasminogen to fibrin

1 reference

12 December 2020

Cross-linking of α2-plasmin inhibitor and fibronectin to fibrin by fibrin-stabilizing factor

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI110479

1 reference

22 September 2017

1 reference

22 September 2017

PubMed publication ID

7199538

1 reference